Endocrine therapy of HER-2/neu negative metastatic breast cancer - revising the bookshelf

被引：0
|
作者：
Lueftner, D. [1 ]
机构：
[1] Charite Campus Benjamin Franklin, Med Klin Hamatol Onkol & Tumorimmunol MS, Berlin, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [21] Targeting Her-2/neu in breast cancer: As easy as this!
    Azim, Hamdy
    Azim, Hatem A., Jr.
    ONCOLOGY, 2008, 74 (3-4) : 150 - 157
  • [22] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [23] HER-2/neu oncogene amplification in breast cancer
    Brien, TP
    Sheehan, CE
    Muraca, PJ
    Stylos, S
    Johnson, RL
    Ross, JS
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S103 - S104
  • [24] HER-2/neu and topoisomerase IIα in breast cancer
    Järvinen, TAH
    Liu, ET
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (03) : 299 - 311
  • [25] Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer
    Ali, Suhail M.
    Carney, Walter P.
    Esteva, Francisco J.
    Fornier, Monica
    Harris, Lyndsay
    Koestler, Wolfgang. J.
    Lotz, Jean-Pierre
    Luftner, Diana
    Pichon, Marie-France
    Lipton, Allan
    CANCER, 2008, 113 (06) : 1294 - 1301
  • [26] HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer
    Konecny, GE
    Thomssen, C
    Lück, HJ
    Untch, M
    Wang, HJ
    Kuhn, W
    Eidtmann, H
    du Bois, A
    Olbricht, S
    Steinfeld, D
    Möbus, V
    von Minckwitz, G
    Dandekar, S
    Ramos, L
    Pauletti, G
    Pegram, MD
    Jänicke, F
    Slamon, DJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15): : 1141 - 1151
  • [27] Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
    Lipton, A
    Ali, SM
    Leitzel, K
    Demers, L
    Chinchilli, V
    Engle, L
    Harvey, HA
    Brady, C
    Nalin, CM
    Dugan, M
    Carney, W
    Allard, J
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1467 - 1472
  • [28] Serum EGFr and HER-2/neu predicts poor survival in metastatic breast cancer
    Hamer, P. J.
    Jarosz, D. E.
    Leitzel, K.
    Ali, S. M.
    Demers, L.
    Evans, D. B.
    Chaudri-Ross, H. A.
    Lipton, A.
    Camey, W. P.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A168 - A168
  • [29] Her-2/neu oncogen amplification in breast cancer
    Canepa, Mariana
    Deninghoff, Valeria
    Perazzo, Florencia
    Paesani, Fernando
    Nieto, Silvana
    Garcia, Alejandro
    Avagnina, Alejandra
    Elsner, Boris
    MEDICINA-BUENOS AIRES, 2012, 72 (01) : 88 - 89
  • [30] HER-2/neu as a predictive marker in breast cancer
    Konecny, G
    Pegram, M
    Untch, M
    Thomssen, C
    Jänicke, F
    Hepp, H
    Slamon, DJ
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2000, 60 (12) : 609 - 619
12345